Company · CIK 1656536
Decibel Therapeutics, Inc.
| CIK | 1656536 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-03-29 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-263671 | 2022-03-18 | 2023-10-06 | 4 | |
| 333-252347 | 2021-01-22 | 2021-02-12 | 6 |
Filings
11| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2023-10-06 | EFFECTDeclared effective | 333-263671 | 9999999995-23-002949 |
| 2022-08-10 | 424B5Shelf takedown | 333-263671 | 0001193125-22-217434 |
| 2022-05-17 | EFFECTDeclared effective | 333-263671 | 9999999995-22-001508 |
| 2022-03-18 | S-3Shelf registered | 333-263671 | 0001193125-22-078944 |
| 2021-02-12 | 424B4Final prospectus | 333-252347 | 0001193125-21-041651 |
| 2021-02-11 | EFFECTDeclared effective | 333-252347 | 9999999995-21-000599 |
| 2021-02-08 | S-1/AAmendment | 333-252347 | 0001193125-21-031447 |
| 2021-02-03 | S-1/AAmendment | 333-252347 | 0001193125-21-027403 |
| 2021-01-28 | S-1/AAmendment | 333-252347 | 0001193125-21-020896 |
| 2021-01-22 | S-1Registration filed | 333-252347 | 0001193125-21-014818 |
| 2020-12-11 | DRSDraft made public | 377-03877 | 0000950123-20-012596 |